Syringaresinol-4-O-β-d-glucoside alters lipid and glucose metabolism in HepG2 cells and C2C12 myotubes

Syringaresinol-4-O-β-d-glucoside alters lipid and glucose metabolism in HepG2 cells and C2C12 myotubes

Syringaresinol-4-O-β-d-glucoside (SSG), a furofuran-type lignan, was found to modulate lipid and glucose metabolism through an activity screen of lipid accumulation and glucose consumption, and was therefore considered as a promising candidate for the prevention and treatment of metabolic disorder,...

Full description

Bibliographic Details
Main Authors: Shuai Wang, Chongming Wu, Xin Li, Yue Zhou, Quanyang Zhang, Fuchao Ma, Jianhe Wei, Xiaopo Zhang, Peng Guo
Format: Article
Language:English
Published: Elsevier 2017-07-01
Series:Acta Pharmaceutica Sinica B
Subjects:
Syringaresinol-4-O-β-d-glucoside
Lipid accumulation
Glucose consumption
Insulin resistance
HepG2
C2C12
Oil red O
Online Access:http://www.sciencedirect.com/science/article/pii/S2211383516304324

Internet

http://www.sciencedirect.com/science/article/pii/S2211383516304324

Similar Items